Purchase Order 75N91024P00183
Award Date
1/30/24
Potential Completion Date
3/29/24
Potential Value
$18K
Federal Agency
National Cancer Institute
Awardee
Advanced Cell Diagnostics, Inc.
Ultimate Awardee
Bio-Techne Corporation
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,128 purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, for reagents. ACD is a division of Bio-Techne Corporation, doing business as Bio-Techne. The firm fixed price order runs from July 31, 2023 through August 31, 2023 for delivery to ACD's Newark, California facility. No additional details were provided on the original solicitation, major subcontractors, or...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $17,942.50 firm fixed-price purchase order to Advanced Cell Diagnostics, Inc. for services to be performed between August 14, 2023 and December 13, 2023. Advanced Cell Diagnostics, Inc. will deliver the requested products or services as the prime contractor. The parent company of Advanced Cell Diagnostics, Inc. is Bio-Techne Corporation. The place of performance will...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $13,507.60 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for advanced cell diagnostics services. Advanced Cell Diagnostics, Inc. will perform as the prime contractor, with its parent company listed as Bio-Techne Corporation. The contract period of performance is from November 13, 2023 through January 5, 2024. It is presumed Advanced Cell Diagnostics, Inc. will provide their...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $16,580 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNAScope under contract number 1187802. Advanced Cell Diagnostics, Inc. will deliver its cell diagnostics technology from its Newark, California location under the eight-month contract ending in March 2024. As part of the National Institutes of Health's medical research efforts, this contract provides RNAScope, a...
Advanced Cell Diagnostics, Inc. has been awarded an $11,183.20 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNAscope assay biological products including kits, reagents and probes. As a leader in molecular pathology, Advanced Cell Diagnostics will supply its proprietary RNAScope platform and accompanying products to support the federal research programs of the Department of Health and Human Services agency....
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $34,831.75 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNA probes. Advanced Cell Diagnostics, Inc. will deliver the requested RNA probes to support research efforts at the Bethesda, Maryland facility under this three-month contract ending September 30, 2023. As a leading biotechnology company, Bio-Techne Corporation is the parent company of Advanced Cell Diagnostics,...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $21,435 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a subsidiary of Bio-Techne Corporation, also doing business as Bio-Techne. The contract is for the delivery of RNAscope reagents, kits, and specific probes to support NICHD's research efforts. As the leading federal sponsor of biomedical research, NIH aims to uncover new knowledge that will lead...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,307.50 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a subsidiary of Bio-Techne Corporation doing business as Bio-Techne. The contract is for the delivery of RNASCOPE HIPLEX assay reagents and probes to support research efforts in Newark, California, over a period of three months concluding on October 31,...
This is a $20,000.00 firm-fixed-price purchase order contract awarded to Advanced Cell Diagnostics, Inc. (ACD) by the National Institute on Drug Abuse, a component of the National Institutes of Health (NIH). The contract is for the delivery of ACD's proprietary RNAscope reagent kits and probes for research applications. ACD, a subsidiary of Bio-Techne Corporation, is a leading provider of molecular diagnostic tools and has been awarded over 50 prime federal contracts, primarily from NIH and...
This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $10,488.08 contract is for the provision of ACD's proprietary RNAscope technology and related products, which enable the visualization and quantification of RNA biomarkers. This contract supports biomedical research efforts across various National Institutes of...